MHR Fund Management - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
MHR Fund Management ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$90,986,819
+7.7%
19,997,103
+66.7%
11.15%
-6.1%
Q2 2023$84,459,605
+15.2%
11,997,1030.0%11.88%
+20.4%
Q1 2023$73,302,299
-4.4%
11,997,1030.0%9.86%
-24.6%
Q4 2022$76,661,48811,997,10313.08%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 11,826,299$130,562,0004.09%
MPM BioImpact LLC 1,200,000$13,248,0003.68%
Finepoint Capital LP 960,200$10,601,0003.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,011$273,000,0002.85%
Avoro Capital Advisors LLC 9,220,000$101,789,0002.01%
Long Focus Capital Management, LLC 1,625,000$17,940,0001.88%
683 Capital Management, LLC 2,000,000$22,080,0001.56%
Parametrica Management Ltd 115,870$1,268,0001.38%
Boxer Capital, LLC 1,935,133$21,364,0001.35%
Soleus Capital Management, L.P. 719,600$7,944,0001.24%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders